See how your answers relate to your colleagues'.

Which below medication is currently in Phase 3 clinical development for the treatment of NASH?
a. Tirzepatide
b. Resmetirom
c. Glimepiride
d. None of the above

Submit is supported by independent educational grants from Insulet Corporation, Madrigal Pharmaceuticals, MannKind Corporation, Medtronic, Stanford University, and Tandem Diabetes Care, Inc.
©2024 CogniMed Inc. All rights reserved.